AI Chatbot Education for Improving HPV Knowledge Among University Students
AIHPV
Effect of an AI Chatbot-Based Educational Program on HPV Knowledge Among University Students
2 other identifiers
interventional
68
1 country
1
Brief Summary
Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide and is associated with several cancers. Adequate knowledge about HPV and vaccination remains limited among university students. This randomized controlled trial aims to evaluate the effectiveness of an artificial intelligence (AI) chatbot-based educational program in improving HPV knowledge among undergraduate nursing students at Cyprus International University. Participants will be randomly assigned to either an AI chatbot-based personalized education group or a control group receiving standard written educational materials. HPV knowledge will be assessed before and after the intervention using the validated HPV Knowledge Questionnaire. The findings will provide evidence regarding the effectiveness of AI-supported educational strategies for improving HPV-related knowledge among university students
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
CompletedFirst Submitted
Initial submission to the registry
June 29, 2026
CompletedFirst Posted
Study publicly available on registry
July 6, 2026
CompletedJuly 7, 2026
July 1, 2026
2 months
June 29, 2026
July 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HPV Knowledge Score
The primary outcome measure assesses changes in participants' knowledge of Human Papillomavirus (HPV) following the educational intervention. HPV knowledge is measured using the validated 29-item HPV Knowledge Questionnaire developed by Waller et al. (2013). The questionnaire evaluates three domains: general HPV knowledge, HPV testing knowledge, and HPV vaccination knowledge. Higher total scores indicate greater HPV-related knowledge
Baseline (before the educational intervention) and 1 month after completion of the educational intervention.
Study Arms (2)
AI Chatbot-Based Education
EXPERIMENTALParticipants in this group received personalized education about Human Papillomavirus (HPV) through an artificial intelligence (AI) chatbot. The educational content was tailored according to each participant's baseline HPV knowledge and covered HPV transmission, risk factors, HPV-related diseases, HPV vaccination, prevention strategies, and common misconceptions
Standard Written Education
ACTIVE COMPARATORParticipants in this group received standard written educational materials covering the same HPV-related topics, including HPV transmission, risk factors, HPV-related diseases, HPV vaccination, and prevention strategies. No personalized feedback or AI chatbot interaction was provided
Interventions
Participants received personalized education through an artificial intelligence (AI) chatbot. Educational content was tailored according to each participant's baseline HPV knowledge and included information on HPV transmission, risk factors, HPV-related diseases, HPV vaccination, prevention strategies, and common misconceptions. The chatbot provided interactive, personalized educational support throughout the intervention
Participants received standard written educational materials covering HPV transmission, risk factors, HPV-related diseases, HPV vaccination, and prevention strategies. The educational materials were identical in content to the intervention group but were provided without personalization or AI chatbot interaction
Eligibility Criteria
You may qualify if:
- All students, both female and male, first semester of bachelor's degree, studying in nursing department Enrollment at Cyprus International University
- Willingness to participate and provide written informed consent
- No prior formal education on HPV
You may not qualify if:
- Withdrawal of consent at any stage of the study
- Failure to complete either the pre-test or post-test assessments
- Incomplete participation in the educational intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pouran Varvani Farahani
Nicosia, North Cyprus, Cyprus
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pouran Varvani Farahani, PhD
PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- To reduce bias, the statistician responsible for data analysis remained blinded to group allocation. Group assignments were coded as Group A and Group B during statistical analysis.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University
Study Record Dates
First Submitted
June 29, 2026
First Posted
July 6, 2026
Study Start
March 1, 2026
Primary Completion
April 20, 2026
Study Completion
May 30, 2026
Last Updated
July 7, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
No There is no plan to make IPD available to other researchers